Advertisement

Topics

CELLnTEC Advanced Cell Systems Company Profile

16:22 EDT 21st June 2018 | BioPortfolio

CELLnTEC's expertise with the development of epithelial progenitor cell culture systems is also available thorugh a selection of unique services.

Location

Laenggassstr 122
Postfach
Bern
CH-3001
Switzerland

Contact

Phone: 41 (0)31 631 2508
Fax: 41 (0)31 631 2635
Email: info@cellntec.com


News Articles [2302 Associated News Articles listed on BioPortfolio]

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia don't respond to chimeric antigen receptor T cell therapy, and the answer is tied to ho...

T cell biomarker predicts which CLL patients will respond to CAR T cell therapy

(University of Pennsylvania School of Medicine) Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don't respond to chimeric antigen...

MD Anderson, Berkeley Lights Launch Cancer Cell Therapy Company

The University of Texas MD Anderson Cancer Center and Berkeley Lights said today they have launched a new biopharma focused on developing cancer cell therapies discovered at MD Anderson, and manufactu...

Advanced Cell Technology:Gary Rabin. Applying Stem Cell-Based Technologies to Create Patient-Specific Therapies

In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Gary Rabin, CEO of Advanced Cell Technology

First-line Pazopanib May Improve Outcomes in Advanced RCC

Treatment-naïve patients with advanced clear-cell renal cell carcinoma had significantly longer progression-free survival when treated with pazopanib instead of temsirolimus.

FDA Approves IO Combo for Advanced Renal Cell Cancer

The approval of the nivolumab and ipilimumab combination provides a new first-line treatment option for a segment of patients with advanced renal cell carcinoma. News Alerts

International Stem Cell to Launch Advanced Joint Supplement

International Stem Cell (OTCQB:ISCO) a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the Company plans ...

CGT Catapult to support UK network of advanced treatment centres

'World First' centres will develop and deliver systems for the delivery of cutting edge cell and gene therapies

PubMed Articles [5497 Associated PubMed Articles listed on BioPortfolio]

Guidelines for Developing Successful Short Advanced Courses in Systems Medicine and Systems Biology.

Cell encapsulation: Overcoming barriers in cell transplantation in diabetes and beyond.

Cell-based therapy is emerging as a promising strategy for treating a wide range of human diseases, such as diabetes, blood disorders, acute liver failure, spinal cord injury, and several types of can...

Encapsulated Optically Responsive Cell Systems: Toward Smart Implants in Biomedicine.

Managing increasingly prevalent chronic diseases will require close continuous monitoring of patients. Cell-based biosensors may be used for implantable diagnostic systems to monitor health status. Ce...

Assessing Inequality in Transcriptomic Data.

Two studies in this issue of Cell Systems use the Gini index from economics to benchmark and quantify gene expression heterogeneity in single-cell or bulk RNA-seq datasets.

Well-Controlled Cell-Trapping Systems for Investigating Heterogeneous Cell-Cell Interactions.

Microfluidic systems have been developed for patterning single cells to study cell-cell interactions. However, patterning multiple types of cells to understand heterogeneous cell-cell interactions rem...

Clinical Trials [11153 Associated Clinical Trials listed on BioPortfolio]

Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.

Rationale: Pancreatic adenocarcinoma is a malignancy with a poor prognosis. Resection is the only curative option and still 5-year survival rate is less than 10 percent. However, most pati...

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

The purpose of the study is to compare the clinical benefit, as measured by duration of overall survival, of Nivolumab vs. Everolimus in subjects with advanced or metastatic clear-cell ren...

A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors

The proposed clinical trial is a phase I, open-label, multi-center, dose-escalation study of ALT-803 in patients with surgically incurable advanced solid tumors: melanoma, renal cell, non-...

Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

The clinical outcome of advanced / metastatic renal cell carcinoma has been changed since targeted therapy being widely applied. This study will retrospectively analyse the clinical outcom...

Trial of X4P--001 in Patients With Advanced Renal Cell Carcinoma

The purpose of the study is to test different doses of X4P-001 given alone and in combination with axitinib in patients diagnosed with advanced renal cell carcinoma. The goals of the study...

Companies [3203 Associated Companies listed on BioPortfolio]

CELLnTEC Advanced Cell Systems

CELLnTEC's expertise with the development of epithelial progenitor cell culture systems is also available thorugh a selection of unique services.

One Cell Systems, Inc.

One Cell Systems is developing and marketing a family of single cell assays that rely on microencapsulation and flow cytometry. Technology underlying these products has been developed internally and l...

ADVANCED CELL & GENE THERAPY, LLC

ADVANCED CELL & GENE THERAPY, LLC, is a consulting firm serving biotechnology companies, clinical laboratories, and biotechnology investors. We provide practical, experienced guidance in development, ...

Biological Industries USA

Biological Industries (www.bioind.com) is one of the world’s leading and trusted suppliers to the life sciences industry, with over 35 years’ experience in cell culture ...

Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.c...

More Information about "CELLnTEC Advanced Cell Systems" on BioPortfolio

We have published hundreds of CELLnTEC Advanced Cell Systems news stories on BioPortfolio along with dozens of CELLnTEC Advanced Cell Systems Clinical Trials and PubMed Articles about CELLnTEC Advanced Cell Systems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CELLnTEC Advanced Cell Systems Companies in our database. You can also find out about relevant CELLnTEC Advanced Cell Systems Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record